NCT00626665View on ClinicalTrials.gov

Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Raynaud Disease
Interventions
DRUG

Tadalafil

Tablets Tadalafil, 20 mg, alternate days, 6 weeks

All Listed Sponsors
lead

Sanjay Gandhi Postgraduate Institute of Medical Sciences

OTHER_GOV

NCT00626665 - Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma | Biotech Hunter | Biotech Hunter